From: Assessment of safety and tolerability of remogliflozin etabonate (GSK189075) when administered with total daily dose of 2000 mg of metformin
PK Parameter
RE 500 mg + Metformin
(Day 13/Day-1)
RE 750 mg + Metformin
AUC(0-tau)
(hr.ng/ml)
1.03 (0.97, 1.09)
1.01 (0.88–1.16)
Cmax
(ng/ml)
0.98 (0.9, 1.08)
0.96 (0.84–1.10)